Cambridge Research Biochemicals Launches DISCOVERY Antibodies Catalogue

News   Feb 21, 2017 | Original Story From Cambridge Research Biochemicals

 
Cambridge Research Biochemicals Launches DISCOVERY Antibodies Catalogue
 
 
 

RELATED ARTICLES

Antitumor Immune Function in Liver Controlled by Gut Microbiome

News

Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. The study showed that bacteria found in the gut of mice affect the liver’s antitumor immune function. The findings have implications for understanding the mechanisms that lead to liver cancer and for therapeutic approaches to treat them.

READ MORE

Tiny Particles Carry Tumor Shrinking Drugs into the Brain

News

MIT researchers have now devised a new drug-delivering nanoparticle that could offer a better way to treat glioblastoma. The particles, which carry two different drugs, are designed so that they can easily cross the blood-brain barrier and bind directly to tumor cells.

READ MORE

Reprogrammed Virus Offers Hope as Cancer Treatment

News

A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility. The team of researchers has successfully ‘trained’ a respiratory virus to recognise ovarian cancer and completely destroy it without infecting other cells. The reprogrammed virus could also be used to treat other cancers such as breast, pancreatic, lung and oral.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy